LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Laud-Duval, Karine"
  2. AU=Mansouri Neda

Search results

Result 1 - 7 of total 7

Search options

  1. Article: Upregulation of the Mevalonate Pathway through EWSR1-FLI1/EGR2 Regulatory Axis Confers Ewing Cells Exquisite Sensitivity to Statins.

    Buchou, Charlie / Laud-Duval, Karine / van der Ent, Wietske / Grossetête, Sandrine / Zaidi, Sakina / Gentric, Géraldine / Corbé, Maxime / Müller, Kévin / Del Nery, Elaine / Surdez, Didier / Delattre, Olivier

    Cancers

    2022  Volume 14, Issue 9

    Abstract: Ewing sarcoma (EwS) is an aggressive primary bone cancer in children and young adults characterized by oncogenic fusions between genes encoding FET-RNA-binding proteins and ETS transcription factors, the most frequent fusion being EWSR1-FLI1. We show ... ...

    Abstract Ewing sarcoma (EwS) is an aggressive primary bone cancer in children and young adults characterized by oncogenic fusions between genes encoding FET-RNA-binding proteins and ETS transcription factors, the most frequent fusion being EWSR1-FLI1. We show that EGR2, an Ewing-susceptibility gene and an essential direct target of EWSR1-FLI1, directly regulates the transcription of genes encoding key enzymes of the mevalonate (MVA) pathway. Consequently, Ewing sarcoma is one of the tumors that expresses the highest levels of mevalonate pathway genes. Moreover, genome-wide screens indicate that MVA pathway genes constitute major dependencies of Ewing cells. Accordingly, the statin inhibitors of HMG-CoA-reductase, a rate-limiting enzyme of the MVA pathway, demonstrate cytotoxicity in EwS. Statins induce increased ROS and lipid peroxidation levels, as well as decreased membrane localization of prenylated proteins, such as small GTP proteins. These metabolic effects lead to an alteration in the dynamics of S-phase progression and to apoptosis. Statin-induced effects can be rescued by downstream products of the MVA pathway. Finally, we further show that statins impair tumor growth in different Ewing PDX models. Altogether, the data show that statins, which are off-patent, well-tolerated, and inexpensive compounds, should be strongly considered in the therapeutic arsenal against this deadly childhood disease.
    Language English
    Publishing date 2022-05-08
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers14092327
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma.

    Surdez, Didier / Zaidi, Sakina / Grossetête, Sandrine / Laud-Duval, Karine / Ferre, Anna Sole / Mous, Lieke / Vourc'h, Thomas / Tirode, Franck / Pierron, Gaelle / Raynal, Virginie / Baulande, Sylvain / Brunet, Erika / Hill, Véronique / Delattre, Olivier

    Cancer cell

    2021  Volume 39, Issue 6, Page(s) 810–826.e9

    Abstract: STAG2, a cohesin family gene, is among the most recurrently mutated genes in cancer. STAG2 loss of function (LOF) is associated with aggressive behavior in Ewing sarcoma, a childhood cancer driven by aberrant transcription induced by the EWSR1-FLI1 ... ...

    Abstract STAG2, a cohesin family gene, is among the most recurrently mutated genes in cancer. STAG2 loss of function (LOF) is associated with aggressive behavior in Ewing sarcoma, a childhood cancer driven by aberrant transcription induced by the EWSR1-FLI1 fusion oncogene. Here, using isogenic Ewing cells, we show that, while STAG2 LOF profoundly changes the transcriptome, it does not significantly impact EWSR1-FLI1, CTCF/cohesin, or acetylated H3K27 DNA binding patterns. In contrast, it strongly alters the anchored dynamic loop extrusion process at boundary CTCF sites and dramatically decreases promoter-enhancer interactions, particularly affecting the expression of genes regulated by EWSR1-FLI1 at GGAA microsatellite neo-enhancers. Down-modulation of cis-mediated EWSR1-FLI1 activity, observed in STAG2-LOF conditions, is associated with enhanced migration and invasion properties of Ewing cells previously observed in EWSR1-FLI1
    MeSH term(s) Bone Neoplasms/genetics ; Bone Neoplasms/mortality ; Bone Neoplasms/pathology ; CCCTC-Binding Factor/chemistry ; CCCTC-Binding Factor/genetics ; CCCTC-Binding Factor/metabolism ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Cell Movement/genetics ; Chromatin Immunoprecipitation ; Chromosomal Proteins, Non-Histone/metabolism ; Enhancer Elements, Genetic ; Gene Expression Regulation, Neoplastic ; Histones/metabolism ; Humans ; Loss of Function Mutation ; Lysine/metabolism ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Promoter Regions, Genetic ; Sarcoma, Ewing/genetics ; Sarcoma, Ewing/mortality ; Sarcoma, Ewing/pathology ; Cohesins
    Chemical Substances CCCTC-Binding Factor ; CTCF protein, human ; Cell Cycle Proteins ; Chromosomal Proteins, Non-Histone ; EWSR1-FLI1 fusion protein, human ; Histones ; Oncogene Proteins, Fusion ; STAG2 protein, human ; Lysine (K3Z4F929H6)
    Language English
    Publishing date 2021-04-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Video-Audio Media
    ZDB-ID 2078448-X
    ISSN 1878-3686 ; 1535-6108
    ISSN (online) 1878-3686
    ISSN 1535-6108
    DOI 10.1016/j.ccell.2021.04.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions

    Vibert, Julien / Saulnier, Olivier / Collin, Céline / Petit, Floriane / Borgman, Kyra J.E. / Vigneau, Jérômine / Gautier, Maud / Zaidi, Sakina / Pierron, Gaëlle / Watson, Sarah / Gruel, Nadège / Hénon, Clémence / Postel-Vinay, Sophie / Deloger, Marc / Raynal, Virginie / Baulande, Sylvain / Laud-Duval, Karine / Hill, Véronique / Grossetête, Sandrine /
    Dingli, Florent / Loew, Damarys / Torrejon, Jacob / Ayrault, Olivier / Orth, Martin F. / Grünewald, Thomas G.P. / Surdez, Didier / Coulon, Antoine / Waterfall, Joshua J. / Delattre, Olivier

    Molecular cell. 2022 July 07, v. 82, no. 13

    2022  

    Abstract: Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TFs) such as EWS::FLI1 in Ewing sarcoma (EwS). Here, we find that EWS::FLI1 induces the robust expression of a specific set of novel spliced and ... ...

    Abstract Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TFs) such as EWS::FLI1 in Ewing sarcoma (EwS). Here, we find that EWS::FLI1 induces the robust expression of a specific set of novel spliced and polyadenylated transcripts within otherwise transcriptionally silent regions of the genome. These neogenes (NGs) are virtually undetectable in large collections of normal tissues or non-EwS tumors and can be silenced by CRISPR interference at regulatory EWS::FLI1-bound microsatellites. Ribosome profiling and proteomics further show that some NGs are translated into highly EwS-specific peptides. More generally, we show that hundreds of NGs can be detected in diverse cancers characterized by chimeric TFs. Altogether, this study identifies the transcription, processing, and translation of novel, specific, highly expressed multi-exonic transcripts from otherwise silent regions of the genome as a new activity of aberrant TFs in cancer.
    Keywords genes ; genomics ; microsatellite repeats ; peptides ; proteomics ; ribosomes ; sarcoma ; transcription (genetics)
    Language English
    Dates of publication 2022-0707
    Size p. 2458-2471.e9.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2022.04.019
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article: Origine cellulaire des tumeurs d'Ewing: un coin de voile est levé.

    Tirode, Franck / Laud-Duval, Karine / Delattre, Olivier

    Medecine sciences : M/S

    2008  Volume 24, Issue 3, Page(s) 248–250

    Title translation Cellular origin of Ewing's tumor. A corner of the veil is lifted.
    MeSH term(s) Adipocytes/cytology ; Adolescent ; Adult ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Cell Differentiation ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/pathology ; Child ; Chondrocytes/cytology ; Gene Expression Regulation, Neoplastic ; Humans ; Mesoderm/pathology ; Models, Biological ; Neoplastic Stem Cells/cytology ; Neoplastic Stem Cells/drug effects ; Oncogene Proteins, Fusion/antagonists & inhibitors ; Oncogene Proteins, Fusion/physiology ; Osteocytes/cytology ; Proto-Oncogene Protein c-fli-1 ; RNA-Binding Protein EWS ; Sarcoma, Ewing/genetics ; Sarcoma, Ewing/pathology ; Stromal Cells/pathology ; Transcription Factors/antagonists & inhibitors ; Transcription Factors/physiology ; Tumor Cells, Cultured/drug effects
    Chemical Substances EWS-FLI fusion protein ; Oncogene Proteins, Fusion ; Proto-Oncogene Protein c-fli-1 ; RNA-Binding Protein EWS ; Transcription Factors
    Language French
    Publishing date 2008-03
    Publishing country France
    Document type News
    ZDB-ID 632733-3
    ISSN 1958-5381 ; 0767-0974
    ISSN (online) 1958-5381
    ISSN 0767-0974
    DOI 10.1051/medsci/2008243248
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions.

    Vibert, Julien / Saulnier, Olivier / Collin, Céline / Petit, Floriane / Borgman, Kyra J E / Vigneau, Jérômine / Gautier, Maud / Zaidi, Sakina / Pierron, Gaëlle / Watson, Sarah / Gruel, Nadège / Hénon, Clémence / Postel-Vinay, Sophie / Deloger, Marc / Raynal, Virginie / Baulande, Sylvain / Laud-Duval, Karine / Hill, Véronique / Grossetête, Sandrine /
    Dingli, Florent / Loew, Damarys / Torrejon, Jacob / Ayrault, Olivier / Orth, Martin F / Grünewald, Thomas G P / Surdez, Didier / Coulon, Antoine / Waterfall, Joshua J / Delattre, Olivier

    Molecular cell

    2022  Volume 82, Issue 13, Page(s) 2458–2471.e9

    Abstract: Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TFs) such as EWS::FLI1 in Ewing sarcoma (EwS). Here, we find that EWS::FLI1 induces the robust expression of a specific set of novel spliced and ... ...

    Abstract Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TFs) such as EWS::FLI1 in Ewing sarcoma (EwS). Here, we find that EWS::FLI1 induces the robust expression of a specific set of novel spliced and polyadenylated transcripts within otherwise transcriptionally silent regions of the genome. These neogenes (NGs) are virtually undetectable in large collections of normal tissues or non-EwS tumors and can be silenced by CRISPR interference at regulatory EWS::FLI1-bound microsatellites. Ribosome profiling and proteomics further show that some NGs are translated into highly EwS-specific peptides. More generally, we show that hundreds of NGs can be detected in diverse cancers characterized by chimeric TFs. Altogether, this study identifies the transcription, processing, and translation of novel, specific, highly expressed multi-exonic transcripts from otherwise silent regions of the genome as a new activity of aberrant TFs in cancer.
    MeSH term(s) Carcinogenesis/genetics ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic/genetics ; Gene Silencing ; Genome/genetics ; Genomics ; Humans ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Oncogenes/genetics ; Proto-Oncogene Protein c-fli-1/genetics ; Proto-Oncogene Protein c-fli-1/metabolism ; Sarcoma, Ewing/genetics ; Sarcoma, Ewing/metabolism ; Sarcoma, Ewing/pathology ; Transcription Factors/genetics ; Transcription, Genetic/genetics
    Chemical Substances Oncogene Proteins, Fusion ; Proto-Oncogene Protein c-fli-1 ; Transcription Factors
    Language English
    Publishing date 2022-05-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2022.04.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Antagonism pattern detection between microRNA and target expression in Ewing's sarcoma.

    Martignetti, Loredana / Laud-Duval, Karine / Tirode, Franck / Pierron, Gaelle / Reynaud, Stéphanie / Barillot, Emmanuel / Delattre, Olivier / Zinovyev, Andrei

    PloS one

    2012  Volume 7, Issue 7, Page(s) e41770

    Abstract: MicroRNAs (miRNAs) have emerged as fundamental regulators that silence gene expression at the post-transcriptional and translational levels. The identification of their targets is a major challenge to elucidate the regulated biological processes. The ... ...

    Abstract MicroRNAs (miRNAs) have emerged as fundamental regulators that silence gene expression at the post-transcriptional and translational levels. The identification of their targets is a major challenge to elucidate the regulated biological processes. The overall effect of miRNA is reflected on target mRNA expression, suggesting the design of new investigative methods based on high-throughput experimental data such as miRNA and transcriptome profiles. We propose a novel statistical measure of non-linear dependence between miRNA and mRNA expression, in order to infer miRNA-target interactions. This approach, which we name antagonism pattern detection, is based on the statistical recognition of a triangular-shaped pattern in miRNA-target expression profiles. This pattern is observed in miRNA-target expression measurements since their simultaneously elevated expression is statistically under-represented in the case of miRNA silencing effect. The proposed method enables miRNA target prediction to strongly rely on cellular context and physiological conditions reflected by expression data. The procedure has been assessed on synthetic datasets and tested on a set of real positive controls. Then it has been applied to analyze expression data from Ewing's sarcoma patients. The antagonism relationship is evaluated as a good indicator of real miRNA-target biological interaction. The predicted targets are consistently enriched for miRNA binding site motifs in their 3'UTR. Moreover, we reveal sets of predicted targets for each miRNA sharing important biological function. The procedure allows us to infer crucial miRNA regulators and their potential targets in Ewing's sarcoma disease. It can be considered as a valid statistical approach to discover new insights in the miRNA regulatory mechanisms.
    MeSH term(s) Computational Biology/methods ; Humans ; MicroRNAs/genetics ; Pattern Recognition, Automated/methods ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Reproducibility of Results ; Sarcoma, Ewing/genetics ; Transcriptome
    Chemical Substances MicroRNAs ; RNA, Messenger
    Language English
    Publishing date 2012-07-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0041770
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Mesenchymal stem cell features of Ewing tumors.

    Tirode, Franck / Laud-Duval, Karine / Prieur, Alexandre / Delorme, Bruno / Charbord, Pierre / Delattre, Olivier

    Cancer cell

    2007  Volume 11, Issue 5, Page(s) 421–429

    Abstract: The cellular origin of Ewing tumor (ET), a tumor of bone or soft tissues characterized by specific fusions between EWS and ETS genes, is highly debated. Through gene expression analysis comparing ETs with a variety of normal tissues, we show that the ... ...

    Abstract The cellular origin of Ewing tumor (ET), a tumor of bone or soft tissues characterized by specific fusions between EWS and ETS genes, is highly debated. Through gene expression analysis comparing ETs with a variety of normal tissues, we show that the profiles of different EWS-FLI1-silenced Ewing cell lines converge toward that of mesenchymal stem cells (MSC). Moreover, upon EWS-FLI1 silencing, two different Ewing cell lines can differentiate along the adipogenic lineage when incubated in appropriate differentiation cocktails. In addition, Ewing cells can also differentiate along the osteogenic lineage upon long-term inhibition of EWS-FLI1. These in silico and experimental data strongly suggest that the inhibition of EWS-FLI1 may allow Ewing cells to recover the phenotype of their MSC progenitor.
    MeSH term(s) Base Sequence ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Cell Differentiation ; Cell Line, Tumor ; DNA Primers ; Humans ; Mesenchymal Stromal Cells/cytology ; Reverse Transcriptase Polymerase Chain Reaction ; Sarcoma, Ewing/genetics ; Sarcoma, Ewing/pathology
    Chemical Substances DNA Primers
    Language English
    Publishing date 2007-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2078448-X
    ISSN 1878-3686 ; 1535-6108
    ISSN (online) 1878-3686
    ISSN 1535-6108
    DOI 10.1016/j.ccr.2007.02.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top